These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
211 related items for PubMed ID: 8258672
1. Persistent hypertension following inhibition of nitric oxide formation in the young Wistar rat: role of renin and vascular hypertrophy. Morton JJ, Beattie EC, Speirs A, Gulliver F. J Hypertens; 1993 Oct; 11(10):1083-8. PubMed ID: 8258672 [Abstract] [Full Text] [Related]
2. Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats. Sventek P, Li JS, Grove K, Deschepper CF, Schiffrin EL. Hypertension; 1996 Jan; 27(1):49-55. PubMed ID: 8591887 [Abstract] [Full Text] [Related]
3. Synergistic Antihypertensive Effect of Carthamus tinctorius L. Extract and Captopril in L-NAME-Induced Hypertensive Rats via Restoration of eNOS and AT₁R Expression. Maneesai P, Prasarttong P, Bunbupha S, Kukongviriyapan U, Kukongviriyapan V, Tangsucharit P, Prachaney P, Pakdeechote P. Nutrients; 2016 Feb 29; 8(3):122. PubMed ID: 26938552 [Abstract] [Full Text] [Related]
4. Comparison of effect of endothelin antagonism and angiotensin-converting enzyme inhibition on blood pressure and vascular structure in spontaneously hypertensive rats treated with N omega-nitro-L-arginine methyl ester. Correlation with topography of vascular endothelin-1 gene expression. Li JS, Deng LY, Grove K, Deschepper CF, Schiffrin EL. Hypertension; 1996 Aug 29; 28(2):188-95. PubMed ID: 8707380 [Abstract] [Full Text] [Related]
5. Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency. Simko F, Luptak I, Matuskova J, Babal P, Pechanova O, Bernatova I, Hulin I. Ann N Y Acad Sci; 2002 Jun 29; 967():454-62. PubMed ID: 12079874 [Abstract] [Full Text] [Related]
6. Effects of captopril on cardiac and renal damage, and metabolic alterations in the nitric oxide-deficient hypertensive rat. Khattab MM, Mostafa A, Al-Shabanah O. Kidney Blood Press Res; 2005 Jun 29; 28(4):243-50. PubMed ID: 16220007 [Abstract] [Full Text] [Related]
7. Hypertension induced by nitric oxide synthesis inhibition is renal nerve dependent. Matsuoka H, Nishida H, Nomura G, Van Vliet BN, Toshima H. Hypertension; 1994 Jun 29; 23(6 Pt 2):971-5. PubMed ID: 8206637 [Abstract] [Full Text] [Related]
8. Effect of salt intake and inhibitor dose on arterial hypertension and renal injury induced by chronic nitric oxide blockade. Yamada SS, Sassaki AL, Fujihara CK, Malheiros DM, De Nucci G, Zatz R. Hypertension; 1996 May 29; 27(5):1165-72. PubMed ID: 8621212 [Abstract] [Full Text] [Related]
9. Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril. Bernátová I, Pechánová O, Pelouch V, Simko F. J Mol Cell Cardiol; 2000 Feb 29; 32(2):177-85. PubMed ID: 10722795 [Abstract] [Full Text] [Related]
10. Vasoactive systems in L-NAME hypertension: the role of inducible nitric oxide synthase. Pechánová O, Dobesová Z, Cejka J, Kunes J, Zicha J. J Hypertens; 2004 Jan 29; 22(1):167-73. PubMed ID: 15106808 [Abstract] [Full Text] [Related]
12. Long-term cardiovascular role of nitric oxide in conscious rats. Hu L, Manning RD, Brands MW. Hypertension; 1994 Feb 29; 23(2):185-94. PubMed ID: 8307627 [Abstract] [Full Text] [Related]
13. ET(A) receptor antagonist ameliorates nephrosclerosis and left ventricular hypertrophy induced in rat by prolonged inhibition of nitric oxide synthesis. Nakamura T, Kurashina T, Saito Y, Sumino H, Akuzawa N, Aizawa H, Sakamoto H, Ono Z, Nagai R. Hypertens Res; 1998 Dec 29; 21(4):251-7. PubMed ID: 9877518 [Abstract] [Full Text] [Related]
14. Effects of chronic increased salt intake on nitric oxide synthesis inhibition-induced hypertension. Fernández-Rivas A, García-Estañ J, Vargas F. J Hypertens; 1995 Jan 29; 13(1):123-8. PubMed ID: 7759842 [Abstract] [Full Text] [Related]
15. Ramipril prevents the detrimental sequels of chronic NO synthase inhibition in rats: hypertension, cardiac hypertrophy and renal insufficiency. Hropot M, Grötsch H, Klaus E, Langer KH, Linz W, Wiemer G, Schölkens BA. Naunyn Schmiedebergs Arch Pharmacol; 1994 Dec 29; 350(6):646-52. PubMed ID: 7535899 [Abstract] [Full Text] [Related]
16. Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats. Bernátová I, Pechánová O, Simko F. Physiol Res; 1996 Dec 29; 45(4):311-6. PubMed ID: 9085355 [Abstract] [Full Text] [Related]
17. Cardiac weight in hypertension induced by nitric oxide synthase blockade. Arnal JF, el Amrani AI, Chatellier G, Ménard J, Michel JB. Hypertension; 1993 Sep 29; 22(3):380-7. PubMed ID: 8349331 [Abstract] [Full Text] [Related]
18. Renoprotective effects of captopril in hypertension induced by nitric oxide synthase inhibition in experimental nephritis. Uhlenius N, Tikkanen T, Miettinen A, Holthöfer H, Törnroth T, Eriksson A, Fyhrquist F, Tikkanen I. Nephron; 1999 Feb 29; 81(2):221-9. PubMed ID: 9933759 [Abstract] [Full Text] [Related]
19. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis]. Gouédard O, Gaudet E, Blanc J, Ponchon P, Elghozi JL. Arch Mal Coeur Vaiss; 1996 Aug 29; 89(8):1013-7. PubMed ID: 8949370 [Abstract] [Full Text] [Related]
20. Chronic nitric oxide synthase inhibition and carotid artery distensibility in renal hypertensive rats. Delacrétaz E, Zanchi A, Nussberger J, Hayoz D, Aubert JF, Brunner HR, Waeber B. Hypertension; 1995 Aug 29; 26(2):332-6. PubMed ID: 7543453 [Abstract] [Full Text] [Related] Page: [Next] [New Search]